Apricot BIO’s platform revolutionizes cancer treatment by capturing the deep molecular phenotype of single cells in response to anti-cancer drugs – An assay we term 4i Drug Response Profiling (4iDRP). This functional response data enables recommendation of the most efficient drug for every individua